Mereo BioPharma (MREO) Enterprise Value Growth (3y) (2020 - 2025)

Mereo BioPharma (MREO) Enterprise Value Growth (3y) (2020 - 2025) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn
4 NuCana 279.75 Bn 279.75 Bn -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn
7 Belite Bio 62.51 Bn 62.51 Bn -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn
9 Revolution Medicines 37.78 Bn 37.78 Bn -
10 Mereo BioPharma 232.52 Mn 232.52 Mn -

Historic Data

Download Data
DateValue
Dec 31, 2025 14.71%
Jun 30, 2025 16.45%
Dec 31, 2024 18.11%
Jun 30, 2024 17.18%
Dec 31, 2023 -22.82%
Jun 30, 2023 9.27%
Dec 31, 2022 -46.49%
Jun 30, 2022 -27.47%
Dec 31, 2021 -53.07%
Dec 31, 2020 23.70%